Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MTEM |
---|---|---|
09:32 ET | 10802 | 2.5819 |
09:34 ET | 6336 | 2.63 |
09:36 ET | 527 | 2.61 |
09:38 ET | 5484 | 2.6101 |
09:39 ET | 2862 | 2.5 |
09:41 ET | 2300 | 2.5 |
09:43 ET | 3842 | 2.6001 |
09:45 ET | 5578 | 2.55 |
09:48 ET | 700 | 2.58 |
09:50 ET | 2550 | 2.595 |
09:52 ET | 4755 | 2.596 |
09:54 ET | 15613 | 2.4 |
09:56 ET | 3300 | 2.45 |
09:57 ET | 600 | 2.41 |
09:59 ET | 3769 | 2.3814 |
10:01 ET | 2281 | 2.38 |
10:03 ET | 2776 | 2.39 |
10:06 ET | 196 | 2.39 |
10:08 ET | 10814 | 2.33 |
10:10 ET | 1700 | 2.33 |
10:12 ET | 2160 | 2.23 |
10:14 ET | 2651 | 2.295 |
10:15 ET | 11424 | 2.39 |
10:19 ET | 502 | 2.35 |
10:21 ET | 6000 | 2.37 |
10:24 ET | 2300 | 2.36 |
10:26 ET | 1500 | 2.4 |
10:30 ET | 900 | 2.375 |
10:42 ET | 400 | 2.37 |
10:46 ET | 1500 | 2.37 |
10:50 ET | 928 | 2.36 |
10:51 ET | 384 | 2.39 |
10:53 ET | 5300 | 2.3 |
10:55 ET | 2406 | 2.3 |
10:57 ET | 1000 | 2.34 |
11:00 ET | 1000 | 2.3145 |
11:02 ET | 1500 | 2.3358 |
11:04 ET | 800 | 2.3 |
11:06 ET | 400 | 2.31 |
11:09 ET | 100 | 2.325 |
11:22 ET | 767 | 2.35 |
11:24 ET | 1710 | 2.3575 |
11:44 ET | 300 | 2.37 |
11:45 ET | 476 | 2.345 |
11:47 ET | 100 | 2.36 |
11:51 ET | 1646 | 2.37 |
11:56 ET | 100 | 2.37 |
11:58 ET | 100 | 2.3615 |
12:02 ET | 100 | 2.375 |
12:07 ET | 100 | 2.375 |
12:12 ET | 100 | 2.34 |
12:14 ET | 297 | 2.36 |
12:20 ET | 250 | 2.39 |
12:23 ET | 500 | 2.35 |
12:30 ET | 100 | 2.355 |
12:41 ET | 1200 | 2.33 |
12:45 ET | 1256 | 2.27 |
12:48 ET | 100 | 2.34 |
12:50 ET | 1099 | 2.2665 |
12:54 ET | 420 | 2.2682 |
12:56 ET | 100 | 2.34 |
12:57 ET | 200 | 2.3487 |
01:15 ET | 1101 | 2.34 |
01:24 ET | 518 | 2.32 |
01:26 ET | 400 | 2.31 |
01:28 ET | 100 | 2.2601 |
01:33 ET | 882 | 2.27 |
01:35 ET | 250 | 2.3235 |
01:39 ET | 100 | 2.34 |
01:48 ET | 100 | 2.35 |
01:55 ET | 100 | 2.33 |
02:04 ET | 100 | 2.31 |
02:06 ET | 100 | 2.26 |
02:09 ET | 5076 | 2.3199 |
02:13 ET | 300 | 2.26 |
02:15 ET | 1143 | 2.31 |
02:22 ET | 500 | 2.31 |
02:29 ET | 100 | 2.32 |
02:36 ET | 14582 | 2.25 |
02:38 ET | 400 | 2.23 |
02:40 ET | 400 | 2.23 |
02:42 ET | 300 | 2.2 |
02:47 ET | 300 | 2.11 |
02:49 ET | 330 | 2.1089 |
02:54 ET | 500 | 2.108 |
03:02 ET | 400 | 2.1001 |
03:03 ET | 1300 | 2.18 |
03:07 ET | 100 | 2.18 |
03:14 ET | 101 | 2.1991 |
03:30 ET | 406 | 2.25 |
03:32 ET | 100 | 2.21 |
03:34 ET | 423 | 2.16 |
03:39 ET | 170 | 2.2 |
03:41 ET | 100 | 2.24 |
03:43 ET | 100 | 2.24 |
03:45 ET | 100 | 2.24 |
03:48 ET | 350 | 2.23 |
03:50 ET | 432 | 2.22 |
03:52 ET | 100 | 2.185 |
03:54 ET | 500 | 2.2185 |
03:56 ET | 400 | 2.2 |
03:57 ET | 1100 | 2.1912 |
03:59 ET | 3640 | 2.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Molecular Templates Inc | 12.0M | -0.3x | --- |
Viaderma Inc | 15.4M | 0.0x | --- |
Emmaus Life Sciences Inc | 5.6M | -1.1x | --- |
Avalo Therapeutics Inc | 17.4M | 0.0x | --- |
SQZ Biotechnologies Co | 1.4M | 0.0x | --- |
Response Genetics Inc | 40.0 | 0.0x | --- |
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted biologic therapeutics. Its drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer. Its product pipeline includes MT-6402, MT-8421 and MT-0169. MT-6402 is an ETB consisting of a single chain variable fragment (scFv), with affinity for PD-L1, fused to the enzymatically active de-immunized Shiga-like toxin-A subunit (SLTA) and a class I antigen derived from the human cytomegalovirus (HCMV). pp65 protein. MT-8421, its ETB targeting CTLA-4, along with MT-6402. MT-0169 focuses on targeting CD38. CD38 is a single-chain type II transmembrane glycoprotein that is expressed by a variety of hematologic cells in an activation- and differentiation-dependent manner.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.0M |
---|---|
Revenue (TTM) | $52.9M |
Shares Outstanding | 5.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-6.69 |
Book Value | $-4.03 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -46.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.